Axim Biotechnologies Inc (AXIM)

[TexasMarvL]

My opinions are my own.
Investors should be very skeptical of AXIM until they can prove the Dry Eye Disease segment can make money.

As for me, I will risk a very small cost at these share price levels in case the DED segment is successful.

As stated before my current number of shares is 1/7th the number of shares I owned in 2020. I purchased half of my existing shares last week.

At this time and at these shares price levels I will add to a small position at a fraction of the cost I paid in 2020.

Please do your own research and make your own decisions.